🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for High Grade Serous Adenocarcinoma of Ovary

Exploratory Study on HER2 Detection Method and Positive Threshold for High-grade Serous Adenocarcinoma of the Ovary NCT06883487n/a1 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: No intervention Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer NCT05080556Phase 21 site📍 London University College, London · Tests: Carboplatin A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer NCT05902988Phase 1, Phase 214 sites📍 Los Angeles📍 Newport Beach📍 Aurora Volastra Therapeutics, Inc. · Tests: VLS-1488 A Study of Sovilnesib in Subjects With Ovarian Cancer NCT06084416Phase 111 sites📍 Birmingham📍 Little Rock📍 Newport Beach Volastra Therapeutics, Inc. · Tests: Sovilnesib Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC NCT04846933NA1 site📍 Turku Turku University Hospital · Tests: WGS and RNA sequencing, circulating tumor DNA (ctDNA), FDG PET/CT imaging This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors NCT06451497Phase 13 sites📍 Boston📍 Austin, TX 78758📍 San Antonio Zumutor Biologics Inc. · Tests: ZM008 Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer NCT05329532Phase 1, Phase 216 sites📍 Brighton📍 Cardiff📍 Edinburgh Scancell Ltd · Tests: Modi-1 Moditope, Pembrolizumab, MicronJet600™ microneedle device (NanoPass) Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer NCT05961124Phase 21 site📍 Toronto Sunnybrook Health Sciences Centre · Tests: Niraparib Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer NCT04794322n/a6 sites📍 Little Rock📍 San Francisco📍 Annapolis Massachusetts General Hospital · Tests: Uterine lavage, or a wash of the womb, Blood sample, Pap smear
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy